Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Obstructive Sleep Apnea
NCT04530747Phase 2Terminated
- Sponsor
- Pennington Biomedical Research Center
- Start
- Jan 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in obstructive sleep apnea (OSA), sponsored by Pennington Biomedical Research Center. Started Jan 2021; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT04530747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530747.